Your browser doesn't support javascript.
loading
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia.
Schäfer, Michaela; Oeing, Christian U; Rohm, Maria; Baysal-Temel, Ezgi; Lehmann, Lorenz H; Bauer, Ralf; Volz, H Christian; Boutros, Michael; Sohn, Daniela; Sticht, Carsten; Gretz, Norbert; Eichelbaum, Katrin; Werner, Tessa; Hirt, Marc N; Eschenhagen, Thomas; Müller-Decker, Karin; Strobel, Oliver; Hackert, Thilo; Krijgsveld, Jeroen; Katus, Hugo A; Berriel Diaz, Mauricio; Backs, Johannes; Herzig, Stephan.
Afiliación
  • Schäfer M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764 Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Man
  • Oeing CU; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heide
  • Rohm M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764 Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120 Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.
  • Baysal-Temel E; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heide
  • Lehmann LH; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heide
  • Bauer R; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany.
  • Volz HC; Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany.
  • Boutros M; Division of Signaling and Functional Genomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany.
  • Sohn D; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764 Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120 Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.
  • Sticht C; Center for Medical Research, University of Mannheim, 68167 Mannheim, Germany.
  • Gretz N; Center for Medical Research, University of Mannheim, 68167 Mannheim, Germany.
  • Eichelbaum K; Department for Cell Signaling and Mass Spectrometry, Max Delbrück Center, 13092 Berlin, Germany.
  • Werner T; Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246 Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246 Hamburg-Eppendorf, Germany.
  • Hirt MN; Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246 Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246 Hamburg-Eppendorf, Germany.
  • Eschenhagen T; Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246 Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246 Hamburg-Eppendorf, Germany.
  • Müller-Decker K; Core Facility Tumor Models, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Strobel O; Department of General Surgery, University of Heidelberg, 69120 Heidelberg, Germany.
  • Hackert T; Department of General Surgery, University of Heidelberg, 69120 Heidelberg, Germany.
  • Krijgsveld J; Genome Biology Unit, EMBL, 69117 Heidelberg, Germany.
  • Katus HA; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany.
  • Berriel Diaz M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764 Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120 Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany.
  • Backs J; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heide
  • Herzig S; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764 Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120 Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Man
Mol Metab ; 5(2): 67-78, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26909315

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Metab Año: 2016 Tipo del documento: Article Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Metab Año: 2016 Tipo del documento: Article Pais de publicación: Alemania